Logo for C4 Therapeutics Inc

C4 Therapeutics Investor Relations Material

Latest events

Logo for C4 Therapeutics Inc

Study Update

C4 Therapeutics
Logo for C4 Therapeutics

Q4 2023

22 Feb, 2024
Logo for C4 Therapeutics

Corporate Presentation

11 Jan, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from C4 Therapeutics Inc

Access all reports
C4 Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on targeted protein degradation to develop novel therapies. The company is active in the development of small-molecule medicines designed to selectively target and degrade disease-causing proteins. C4 Therapeutics is leveraging its proprietary technology platforms to advance a pipeline of drug candidates aimed at treating a range of diseases, such as cancer, neurodegenerative conditions, infectious diseases, and autoimmune disorders. The company is headquartered in Watertown, Massachusetts, and its shares are listed on the Nasdaq under the symbol CCCC.